National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  LAD
  LCID
  LCMI
  LHD
  LHBP
  LIG
  LI
  LIP
  LID
  LIR
  LICP
  MVDB
  LMVR
  LMI
  LMM
  LPD
  LPVD
   Retroviral Immunology
   Retroviral Molecular Biology
   Retroviral Neuropathogenesis
   Tick-Borne Flavivirus Pathogenesis
   TSE/Prion and Retroviral Pathogenesis
   TSE/Prion Biochemistry
   TSE/Prion Cell Biology
   TSE/Prion Molecular Biology
   Veterinary Biology
  LVD
  LZP
  PSIIM
  Research Technologies
  Vaccine Research Center
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Persistent Viral Diseases

Bruce W. Chesebro, M.D., Chief

The Laboratory of Persistent Viral Diseases (LPVD) is concerned with studies of persistent active or latent viral or prion disease infections. Investigators place particular emphasis on persistent infections of the nervous system and of the hemopoietic and lymphoid systems. The laboratory is also studying the roles of persistent infection in the development of retrovirus-induced immunosuppression. Models being examined include prion diseases of various species, murine and human retroviruses, and tick-borne encephalitis viruses.

The major research goals of the laboratory are to understand basic pathogenic mechanisms induced by these infections, to study immune or other defense mechanisms used by infected individuals against infections, and to develop drug therapies capable of reducing or eliminating such infections.

Major Areas of Research

  • Study of the nature of the transmissible agent responsible for prion diseases
  • Study of the pathogenesis of prion diseases using biochemical, cell culture, and animal model methods
  • Development of drug therapies for prion diseases
  • Characterization of mechanisms of pathogenesis, immunosuppression, and immunity of retroviral infection in animals and humans with particular reference to infections involving hematopoietic cells and brain cells
  • Study of genetic control of host defense mechanisms against retroviral diseases, including leukemia and CNS degenerative disease
  • Study of the effects of viral genes on the pathogenesis of Langat virus and other members of the tick-borne encephalopathy family
  • Study of the biochemistry of retroviral recombination with endogenous viral DNA as well as the generation of retroviral variants in different cell types

TSE/Prion and Retroviral Pathogenesis Section

Bruce W. Chesebro, M.D., Chief

TSE/Prion Cell Biology Section

Gerald S. Baron, Ph.D.

Tick‑Borne Flavivirus Pathogenesis Section

Marshall E. Bloom, M.D.

TSE/Prion Biochemistry Section

Byron Caughey, Ph.D.

Retroviral Molecular Biology Section

Leonard H. Evans, Ph.D.

Retroviral Immunology Section

Kim J. Hasenkrug, Ph.D. 

Retroviral Neuropathogenesis Section

John L. Portis, M.D.

TSE/Prion Molecular Biology Section

Suzette A. Priola, Ph.D.

Veterinary Biology Unit

Richard E. Race, D.V.M.

back to top


Contact Info

Bruce W. Chesebro, M.D.
Phone: 406-363-9354
Fax: 406-363-9286
E-mail:
bchesebro@niaid.nih.gov


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in Labs at NIAID
 
Print Icon Print this page
E-mail Icon E-mail this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.


Contact Info

Bruce W. Chesebro, M.D.
Phone: 406-363-9354
Fax: 406-363-9286
E-mail:
bchesebro@niaid.nih.gov


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)